BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20816189)

  • 1. Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma.
    Rabinovitch N; Graber NJ; Chinchilli VM; Sorkness CA; Zeiger RS; Strunk RC; Bacharier LB; Martinez FD; Szefler SJ;
    J Allergy Clin Immunol; 2010 Sep; 126(3):545-51.e1-4. PubMed ID: 20816189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
    Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
    J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
    Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
    J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
    Zeiger RS; Szefler SJ; Phillips BR; Schatz M; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM;
    J Allergy Clin Immunol; 2006 Jan; 117(1):45-52. PubMed ID: 16387583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
    Rabinovitch N; Mauger DT; Reisdorph N; Covar R; Malka J; Lemanske RF; Morgan WJ; Guilbert TW; Zeiger RS; Bacharier LB; Szefler SJ
    J Allergy Clin Immunol; 2014 Feb; 133(2):350-6. PubMed ID: 24084071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma.
    Knuffman JE; Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Martinez FD; Bacharier LB; Strunk RC; Szefler SJ; Zeiger RS; Taussig LM;
    J Allergy Clin Immunol; 2009 Feb; 123(2):411-6. PubMed ID: 19121860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction.
    Rabinovitch N; Zhang L; Gelfand EW
    J Allergy Clin Immunol; 2006 Sep; 118(3):635-40. PubMed ID: 16950282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
    Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
    Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma.
    Cai C; Yang J; Hu S; Zhou M; Guo W
    Lung; 2007; 185(2):105-12. PubMed ID: 17393242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
    Jartti T
    Eur J Pediatr; 2008 Jul; 167(7):731-6. PubMed ID: 18214538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene D4 inhalation challenge for predicting short-term efficacy of montelukast: a pilot study.
    Guan WJ; Shi X; Zheng JP; Gao Y; Jiang CY; Xie YQ; Liu QX; Zhu Z; Guo E; An JY; Yu XX; Liu WT; Zhong NS
    Clin Respir J; 2015 Jan; 9(1):111-20. PubMed ID: 24506412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma.
    Montuschi P; Mondino C; Koch P; Ciabattoni G; Barnes PJ; Baviera G
    Chest; 2007 Dec; 132(6):1876-81. PubMed ID: 18079221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of leukotriene e(4) to exhaled nitric oxide and the therapeutic response in children with exercise-induced bronchoconstriction.
    Baek HS; Cho J; Kim JH; Oh JW; Lee HB
    Allergy Asthma Immunol Res; 2013 Jan; 5(1):26-33. PubMed ID: 23277875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
    Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ
    Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level environmental tobacco smoke exposure and inflammatory biomarkers in children with asthma.
    Gill R; Krishnan S; Dozor AJ
    J Asthma; 2014 May; 51(4):355-9. PubMed ID: 24580138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Chinchilli VM; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bloomberg GR; Covar RA; Guilbert TW; Heldt G; Larsen G; Mellon MH; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
    J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast in pediatric asthma management.
    Walia M; Lodha R; Kabra SK
    Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.